Prognostic significance of TNFRSF4 expression and development of a pathomics model to predict expression in hepatocellular carcinoma

  • 0Department of Interventional Radiology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

|

|

Summary

This summary is machine-generated.

Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) expression and a new pathomics model show promise as prognostic markers for hepatocellular carcinoma (HCC) survival. Gender impacts how these markers relate to patient outcomes.

Area Of Science

  • Oncology
  • Molecular Biology
  • Pathology

Background

  • Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is implicated in cancer progression, particularly in hepatocellular carcinoma (HCC).
  • Understanding TNFRSF4's prognostic value in HCC is crucial for improving patient outcomes.

Purpose Of The Study

  • To investigate the prognostic significance of TNFRSF4 expression in HCC patients.
  • To develop and validate a predictive pathomics model for TNFRSF4 expression in HCC.

Main Methods

  • RNA-sequencing analysis of HCC patient cohort from TCGA database to assess TNFRSF4 expression and overall survival (OS).
  • Hematoxylin-eosin staining and analysis to construct a pathomics model for predicting TNFRSF4 expression.
  • Pathway enrichment, immune checkpoint marker, and immune cell infiltration analyses to elucidate biological mechanisms.

Main Results

  • TNFRSF4 expression was elevated in HCC tumor tissues and correlated with advanced pathologic stage and residual tumor status.
  • Higher TNFRSF4 expression was linked to unfavorable OS, especially in male HCC patients.
  • The pathomics model accurately predicted TNFRSF4 expression and associated high scores with worse OS and increased mortality risk in males, implicating pathways like EMT and Tregs.

Conclusions

  • TNFRSF4 expression and pathomics scores serve as potential prognostic biomarkers for HCC OS.
  • Gender is a significant factor influencing the prognostic association of TNFRSF4 and pathomics scores in HCC.